Post-approval studies (Phase 4)Study completedNCT01519661
What this trial is testing
Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
Who this might be right for
Pulmonary InfectionsPseudomonas Aeruginosa in Cystic Fibrosis
Novartis Pharmaceuticals 157